Regulation of cortical and subcortical glutamate receptor subunit expression by antipsychotic drugs

Journal of Neuroscience

Volumn 15, Issue 3 II, 1995, Pages 2453-2461

  Fitzgerald, Lawrence W ^a   Deutch, Ariel Y ^a   Gasic, Gregory ^b   Heinemann, Stephen F ^b   Nestler, Eric J ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

clozapine; dopamine; NMDA; prefrontal cortex; schizophrenia; striatum

Indexed keywords

CLOZAPINE; GLUTAMATE RECEPTOR; HALOPERIDOL;

ANIMAL EXPERIMENT; ARTICLE; BRAIN FUNCTION; DOPAMINE METABOLISM; DRUG MECHANISM; GENE EXPRESSION REGULATION; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA;

EID: 0028947052     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.15-03-02453.1995     Document Type: Article

References (63)

1. Akbarian S, Bunney WE Jr, Potkin SG, Wigal SB, Hagman JO, Sandman CA, Jones EG (1993) Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenias implies disturbances in cortical development. Arch Gen Psychiatry 50:169-177.
2. Albin RL, Young AB, Penney JB (1989) The functional anatomy of basal ganglia disorders. Trends Neurosci 12:366-375.
3. 3H]SCH 23390 binding to dopamine receptors in vivo in mouse brain. Eur J Pharmacol 146:113-120.
4. Anwyl R (1991) The role of the metabotropic receptor in synaptic plasticity. Trends Pharmacol Sci 12:324-326.
5. Bai G, Kusiak JW (1993) Cloning and analysis of the 5′ flanking sequence of the rat N-methyl-D-aspartate receptor 1 (NMDAR1) gene. Biochim Biophys Acta 1152:197-200.
6. Baldessarini RJ, Centorrino F, Flood JG, Volpicelli SA, Huston-Lyons D, Cohen BM (1993) Tissue concentrations of clozapine and its metabolites in the rat. Neuropsychopharmacology 9:117-124.
7. Beitner-Johnson D, Nestler EJ (1991) Morphine and cocaine exert common chronic actions on tyrosine hydroxylase in dopaminergic brain reward regions. J Neurochem 57:344-347.
8. Benes FM, McSparren J, Bird ED, SanGiovanni JP, Vincent SL (1991) Deficits in small interneurons in prefrontal and cingulate cortex of schizophrenic and schizoaffective patients. Arch Gen Psychiatry 48: 996-1001.
9. Benes FM, Vincent SL, Alsterberg G, Bird ED, SanGiovanni JP (1992) Increased GABA-A receptor binding in superficial layers of schizophrenic cingulate cortex. J Neurosci 12:924-926.
10. Berman KF, Weinberger DR (1990) The prefrontal cortex in schizophrenia and other neuropsychiatrie: in vivo physiological correlates of cognitive deficits. In: The prefrontal cortex: its structure, function, and pathology (Uylings HBM, Van Eden CG, De Bruin JPC, Corner MA, Feenstra MPG, eds). pp 521-538. Amsterdam: Elsevier.
11. Bettler B, Boulter J, Hemans-Borgmeyer I, O'Shea-Greenfield A, Deneris ES, Moll C, Borgmeyer U, Hollmann M, Heinemann S (1990) Cloning of a novel glutamate receptor subunit, GLUR5: expression in the nervous system during development. Neuron 5:583-595.
12. Boulter J, Hollmann M, O'Shea-Greenfield A, Hartley M, Deneris E, Maron C, Heinemann S (1990) Molecular cloning and functional expression of glutamate receptor subunit genes. Science 249:1033-1037.
13. Carlsson M, Carlsson A (1990) Interactions between glutamatergic and monaminergic systems within the basal ganglia - implications for schizophrenia and Parkinson's disease. Trends Neurosci 13:272-276
14. Collingridge GL, Singer W (1990) Excitatory amino acid receptors and synaptic plasticity. Trends Pharmacol Sci 11:290-296.
15. Creese I, Burt DR, Snyder SH (1976) Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 192:481-483.
16. Csernansky JG, Wrona CT, Bardgett ME, Early TS, Newcomer JW (1993) Subcortical dopamine and serotonin turnover during acute and subchronic administration of typical and atypical neuroleptics. Psychopharmacology 110:145-151.
17. Daly DA, Moghaddam B (1993) Actions of clozapine and haloperidol on the extracellular levels of excitatory amino acids in the prefrontal cortex and striatum on conscious rats. Neurosci Lett 152:61-64.
18. Deutch AY (1993) Prefrontal cortical dopamine system and the claboration of functional corticostriatal circuits: implication for schizophrenia and Parkinson's disease. J Neural Transm 91:197-221.
19. Deutch AY, Moghaddam B, Innis RB, Krystal JH, Aghajanian GK, Bunney BS, Charney DS (1991) Mechanisms of action of atypical antipsychotic drugs: implications for novel therapeutic strategies for schizophrenia. Schizophr Res 4:121-156.
20. DiChiara G, Morelli M, Consolo S (1994) Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/NMDA interactions. Trend Neurosci 17:228-232.
21. Farde L, Wiesel FA, Halldin C, Sedvall G (1988) Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs. Arch Gen Psychiatry 45:71.
22. Gellman RL, Aghajanian GK (1993) Pyramidal cells in piriform cortex receive a convergence of inputs from monoamine activated GABAergic interneurons. Brain Res 600:63-73.
23. Gerten CR (1992) The neostriatal mosaic: multiple levels of compartmental organization. Trends Neurosci 15:133-139.
24. Grace AA (1993) Cortical regulation of subcortical dopamine systems and its possible relevance to schizophrenia. J Neural Transm 91:111-134.
25. Grobin AC, Deutch AY (1994) Apomorphine increases extracellular GABA levels in the prefrontal cortex of the freely moving conscious rat. Soc Neurosci Abstr 20:1154.
26. Hollmann M, Heinemann S (1994) Cloned glutamate receptors. Annu Rev Neurosci 17:31-108.
27. Hollmann M, O'Shea-Greenfield A, Rogers SW, Heinemann S (1989) Cloning by functional expression of a member of the glutamate receptor family. Nature 342:643-648.
28. Hyman SE, Nestler EJ (1993) The molecular foundations of psychiatry. Washington, DC: American Psychiatric.
29. Ishii T, Moriyoshi K, Sugihara H, Sakurada K, Kadotani H, Yokoi M, Akazawa C, Shigemoto R, Mizuno N, Masu M, Nakanishi S (1993) Molecular characterization of the family of the N-methyl-D-aspartate receptor subunits. J Biol Chem 268:2836-2843.
30. Krystal JH, Karger LP, Seibyl JP, Freeman G, Delaney R, Bremner JD, Heninger GR, Bowers MB, Charney DS (1994) Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 51:199-214.
31. 1 receptor antagonists: a quantitative audioradiographic study. Eur J Pharmacol 210:195-200.
32. Leysen JE, Van Gompel P, Gommeren W, Woestenborghs R, Janssen PAJ (1986) Down regulation of serotonin-S2 receptor sites in rat brain by chronic treatment with the serotonin-S2 antagonists: ritanserin and septoperone. Psychopharmacology 88:434-444.
33. Lieberman JA (1993) Understanding the mechanism of action of atypical antipsychotic drugs: a review of compounds in use and development. Br J Psychiatry 163:7-18.
34. Martin LJ, Blackstone CD, Levey AI, Huganir RL, Price DL (1993) AMPA glutamate receptor subunits are differentially distributed in rat brain. Neuroscience 53:327-358.
35. Meltzer HY (1991) The mechanism of action of novel antipsychotic drugs. Schizophr Bull 17:263-287.
36. Moghaddam B (1994) Recent basic findings in support of excitatory amino acid hypotheses of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 18:859-870.
37. Monaghan DT, Bridges RJ, Cotman CW (1989) The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system. Annu Rev Pharmacol Toxicol 29:365-402.
38. Monyer H, Sprengel R, Schoepfer R, Herb A, Higuchi M, Lomeli H, Burnashev N, Sakmann B, Seeberg PH (1992) Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science 256:1217-1221.
39. Moriyoshi K, Masu M, Ishii T, Shigemoto R, Mizuno N, Nakanishi S (1991) Molecular cloning and characterization of the rat NMDA receptor. Nature 354:31-37.
40. Nakanishi S (1992) Molecular diversity of glutamate receptors and implications for brain function. Science:597-603.
41. Paxinos G, Watson CW (1986) The rat brain in stereotaxic coordinates, 2d ed. Sydney: Academic.
42. Penney JB, Wullner U, Catnia MV, Standaert DG, Testa CM, Landwehrmeyer GB, Dure LS, Young AB (1993) Glutamate receptor expression in rat striatum: effect of deafferentation. Soc Neurosci Abstr 19:1355.
43. Peroutka SJ, Snyder SH (1980) Relationship of neuroleptic drug effects at brain dopamine, serotonin, α-adrenergic, and histamine receptors to clinical potency. Am J Psychiatry 137:1518-1522.
44. Petralia RS, Yokotani N, Wenthold RJ (1994) Light and electron microscope distribution of the NMDA receptor subunit NMDAR1 in the rat nervous system using a selective anti-peptide antibody. J Neurosci 14:667-696.
45. Puchalski RB, Louis J-C, Brose N, Traynelis SF, Egebjerg J, Kukekov V, Wenthold RJ, Rogers SW, Lin F, Moran T, Morrison JH, Heinemann SF (1994) Selective RNA editing and subunit assembly of native glutamate receptors. Neuron 13:131-147.
46. 3H]GABA on rat prefrontal cortical slices. Neuroscience 42:61-71.
47. Reynolds GP, Garrett NJ, Rupniak N, Jenner P, Marsden C (1983) Chronic clozapine treatment of rats down-regulates cortical 5-HT2 receptors. Eur J Pharmacol 89:325-326.
48. 2 receptor mRNA levels. Eur J Pharmacol 207:169-172.
49. Rupniak NMJ, Mann S, Hall MD, Fleminger S, Kilpatrick G, Jenner P, Marsden CD (1984) Differential effects of continuous administration for 1 year of haloperidol or sulpiride on striatal dopamine function in the rat. Psychopharmacology 84:503-511.
50. See RE, Ellison G (1990) Comparison of chronic administration of haloperidol and the atypical neuroleptics, clozapine and raclopride, in an animal model of tardive dyskinesia. Eur J Pharmacol 181:175-186.
51. Seeman P, Guan HC, Van Tol HHM (1993) Dopamine D4 receptors elevated in schizophrenia. Nature 365:441-445.
52. Siegel SJ, Brose N, Janssen WG, Gasic GP, Jahn R, Heinemann SF, Morrison JH (1994) Regional, cellular, and ultrastructural distribution of N-methyl-n-aspartate receptor subunit 1 in monkey hippocampus. Proc Natl Acad Sci USA 91:564-568.
53. Tamminga CA, Gerlach J (1987) New neuroleptics and experimental antipsychotic in schizophrenia. In: Psychopharmacology - the third generation in progress (Meltzer, HY. ed), p 441. New York: Raven.
54. Titeler M, Seeman P (1980) Radioligand labeling of pre- and postsynaptic dopamine receptors. Adv Biochem Psychopharmacol 24:159.
55. Trevisan L, Fitzgerald LW, Brose N, Gasic GP, Heinemann SF, Duman RS, Nestler EJ (1994) Chronic ingestion of ethanol up-regulates NMDAR1 receptor immunoreactivity in rat hippocampus. J Neurochem 62:1635-1638.
56. Vickers JC, Huntley GW, Edwards AM, Moran T, Rogers SW, Heinemann SF, Morrison JH (1993) Quantitative localization of AMPA/ Kainate and kainate glutamate receptor subunit immunoreactivity in neurochemically identified subpopulations of neurons in the prefrontal cortex of the macaque monkey. J Neurosci 13:2982-2992.
57. Vincent SL, Adamec E, Sorensen I, Benes FM (1994) The effects of chronic haloperidol administration on GABA-immunoreactive axon terminals in rat medial prefrontal cortex. Synapse 17:26-35.
58. Volavka J, Cooper T, Czobor P, Bitter I, Meisner M, Laska E, Gastanaga P, Krakowski M, Chou J, Crowner M, Douyon R (1992) Haloperidol blood levels and clinical effects. Arch Gen Psychiatry 49:354-361.
59. Weinberger DR (1987) Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 44:660-669.
60. Wenthold RJ, Yokotani N, Doi K, Wada K (1992) Immunochemical characterization of the non-NMDA glutamate receptor using subunit-specific antibodies: evidence for hetero-oligomeric structure in rat brain. J Biol Chem 267:501-507.
61. Werner P, Voigt M, Keinänen K, Wisden W, Seeburg PH (1991) Cloning of a putative high-affinity kainate expressed predominantly in hippocampal CA3 cells. Nature 351:742-744.
62. Wilk S, Stanley M (1978) Clozapine concentrations in brain regions: relationship to dopamine metabolite increase. Eur J Pharmacol 51: 101-107.
63. Wüllner U, Brouillet E, Isacson O, Young AB, Penney JB (1993) Glutamate receptor binding sites in MPTP-treated mice. Exp Neurol 121: 284-287.